New fusion tech aims to catch aggressive prostate cancer earlier
NCT ID NCT05064111
First seen Jan 05, 2026 · Last updated Apr 29, 2026 · Updated 22 times
Summary
This study tests a new software that combines MRI and ultrasound images in real time to help doctors more accurately detect and locate aggressive prostate cancer during biopsy. About 100 men scheduled for a standard prostate biopsy will take part. The goal is to improve early diagnosis and help choose the best treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Arizona
Tucson, Arizona, 85724, United States
Conditions
Explore the condition pages connected to this study.